 |
 |

Changes in the Use of Carotid Revascularization Among the Medicare Population
Philip P. Goodney, MD, MS;
F. Lee Lucas, PhD;
Donald S. Likosky, PhD;
David J. Malenka, MD, MS;
Elliott S. Fisher, MD, MPH
Arch Surg. 2008;143(2):170-173.
Hypothesis It remains unknown if the increasing use of carotid artery stenting (CAS) has caused a change in the population-based use of carotid endarterectomy (CEA). We sought to examine national trends in carotid revascularization.
Design Retrospective cohort study.
Setting Academic research.
Patients All Medicare beneficiaries (MCBEs) between January 1, 1998, through December 31, 2004.
Main Outcome Measures We examined the frequency of CEA and CAS using Current Procedural Terminology codes for CEA, peripheral stent insertion, and cerebrovascular disease. To exclude patients who underwent stenting of a peripheral artery other than the carotid artery, we excluded all patients with a primary diagnostic code for peripheral vascular disease.
Results We identified 134 194 claims for carotid revascularization (9386 claims for CAS and 124 808 claims for CEA). The overall incidence of carotid revascularization procedures decreased slightly between 1998 and 2004, from 388.1 to 345.8 procedures per 100 000 MCBEs (11% decrease, P < .02). Between 1998 and 2004, the incidence of CEA decreased from 373.4 to 309.3 procedures per 100 000 MCBEs (17% decrease, P < .01), while the incidence of CAS increased from 14.6 to 36.4 procedures per 100 000 MCBEs (149% increase, P < .01).
Conclusions While rates of carotid revascularization in the Medicare population slightly decreased between 1998 and 2004, the use of CAS dramatically increased. Whether this represents a substitution of CAS for CEA vs a broadening of indications for carotid revascularization using CAS is unknown but is of interest to patients and third-party payers and requires future investigation.
Author Affiliations: Section of Vascular Surgery (Dr Goodney) and Department of Cardiology (Dr Malenka), Dartmouth-Hitchcock Medical Center, Lebanon, and Center for Evaluative Clinical Sciences (Drs Likosky, Malenka, and Fisher), Dartmouth Medical School, Hanover, New Hampshire; Center for Outcomes Research and Evaluation, Maine Medical Center, Portland (Dr Lucas); and Veterans Affairs (VA) Outcomes Group, VA Medical Center, White River Junction, Vermont (Dr Fisher).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association
Writing Group Members et al.
Circulation 2012;125:e2-e220.
FULL TEXT
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Goldstein et al.
Stroke 2011;42:517-584.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association
Roger et al.
Circulation 2011;123:e18-e209.
FULL TEXT
Trends in Endoscopic Sinus Surgery Rates in the Medicare Population
Venkatraman et al.
Arch Otolaryngol Head Neck Surg 2010;136:426-430.
ABSTRACT
| FULL TEXT
Regional Variation in Carotid Artery Stenting and Endarterectomy in the Medicare Population
Goodney et al.
Circ Cardiovasc Qual Outcomes 2010;3:15-24.
ABSTRACT
| FULL TEXT
The Cart and The Horse: The Advancing Technology of Carotid Artery Stenting
Goldstein
Circ Cardiovasc Interv 2009;2:153-155.
FULL TEXT
|